Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 30835
Biosynthesis and In vitro Studies of Silver Bionanoparticles Synthesized from Aspergillusspecies and its Antimicrobial Activity against Multi Drug Resistant Clinical Isolates

Authors: M. Saravanan


Antimicrobial resistant is becoming a major factor in virtually all hospital acquired infection may soon untreatable is a serious public health problem. These concerns have led to major research effort to discover alternative strategies for the treatment of bacterial infection. Nanobiotehnology is an upcoming and fast developing field with potential application for human welfare. An important area of nanotechnology for development of reliable and environmental friendly process for synthesis of nanoscale particles through biological systems In the present studies are reported on the use of fungal strain Aspergillus species for the extracellular synthesis of bionanoparticles from 1 mM silver nitrate (AgNO3) solution. The report would be focused on the synthesis of metallic bionanoparticles of silver using a reduction of aqueous Ag+ ion with the culture supernatants of Microorganisms. The bio-reduction of the Ag+ ions in the solution would be monitored in the aqueous component and the spectrum of the solution would measure through UV-visible spectrophotometer The bionanoscale particles were further characterized by Atomic Force Microscopy (AFM), Fourier Transform Infrared Spectroscopy (FTIR) and Thin layer chromatography. The synthesized bionanoscale particle showed a maximum absorption at 385 nm in the visible region. Atomic Force Microscopy investigation of silver bionanoparticles identified that they ranged in the size of 250 nm - 680 nm; the work analyzed the antimicrobial efficacy of the silver bionanoparticles against various multi drug resistant clinical isolates. The present Study would be emphasizing on the applicability to synthesize the metallic nanostructures and to understand the biochemical and molecular mechanism of nanoparticles formation by the cell filtrate in order to achieve better control over size and polydispersity of the nanoparticles. This would help to develop nanomedicine against various multi drug resistant human pathogens.

Keywords: Nanomedicine, Antimicrobial activity, UV-visible spectroscopy, Bionanoparticles, AtomicForce Microscopy, Extracellular synthesis, Multi drug resistant

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1915


[1] F Gad, T Zahra, KP Francis, T Hasan, MR Hamblin; Photochem .Photobiol. Sci., 3, 451-458 (2004).
[2] O.V Salata; Review, Application of Nanoparticles in biology and medicine, J.Nanobiotechnol., 2 (3), 3-6 (2004).
[3] M. Deendayal, E.M. Bolander, D. Mukhopadhyay, G. Sarkar, P. Mukherjee; Appl. Microbiol. Biotechnol., 69, 485-492 (2006).
[4] T. Klaus, R. Joerger, E. Olsson, C.G Granqvist.; Proc Natl Acad Sci USA 999., 96:13611.
[5] B. Nair, T. Pradeep; Cryst Growth Des., 2, 293 (2002).
[6] M. Kowshik, S. Ashtaputre, S. Kharrazi, W. Vogel, J. Urban, S.K Kulkarni, et al; Nanotechnology., 14, 95 (2003).
[7] P. Mukherjee, A. Ahmad, D. Mandal, S. Senapati, S.R Sainkar, M.I. Khan, et al; Nano. Lett., 1, 515 (2001)
[8] A. Ahmad, P. Mukherjee, S. Senapati , D. Mandal, M.I Khan, R. Kumar, et al; Colloids Surf B Biointerfaces., 28, 313-318 (2003)
[9] A.Ahmad, S. Senapati, M.I Khan, R. Kumar, R. Ramani, V. Srinivas, et al; Nanotechnology., 14, 824-828 (2003)
[10] A. Vigneshwaran, A.A. Kathe, P.V. Varadarajan, R.P. Nachne, R.H. Balasubramanya; Colloids Surf B Biointerfaces., 53, 55-59 (2006).
[11] S. Basavaraja,D. Balaji , A. Lagashetty , A.H. Rajasab, A.Venkataraman; Mater.Res.Bull.(in press)
[12] M. Sastry, A. Ahmad, M.I. Khan, R. Kumar; Curr. Sci., 85, 162-170 (2003).
[13] J.D. Holmes, P.R. Smith, R. Evans-Gowing, D.J. Richardson, D.A. Russel, J.R. Sodeau; Arch. Microbiol., 163, 143-147 (1995).
[14] G.I.H. Souza, P.D Marcato, N. Durán, E. Esposito; IX National Meeting of Environmental Microbiology. Curtiba, PR (Brazil).,( 2004)
[15] M. Saravanan, A. Nanda, Colloids and Surfaces B: Biointerfaces 77, 214 - 218 (2010)
[16] S. Shrivastava, T. Bera, A. Roy, G Singh, P. Ramachandrarao, D. Dash; Nanotechnology., 18, 225103 (2007).
[17] P. Nathan, E.J. Law and D.F Murphy; Burns., 4, 177-178 (1978).
[18] A.Ingle,A. Gade, S.Pierrat, C. Sonnichsen, M. Rai; Curr Nanosci., 4, 141-144 (2008)
[19] M. Sastry, A. Ahmad, M.I Khan, R. Kumar; Curr Sci., 85 162-170 (2003).
[20] R. Sanghi, P. Verma; Bioresour Technol., 100 501-504. (2009).
[21] A.Nanda, M.Saravanan; Nanomedicine; Nanotechnology, biology and medicine. 5, 452-456 (2009)